Posts Tagged ‘vitamin d study’

Study CONFIRMS raising vitamin D levels could reduce MS relapses by 50%

Thursday, August 12th, 2010 | Tags: , , , , , , , , , , , , , , , , , , , , , , ,
Posted in External News Articles, Uncategorized

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.

Abstract

OBJECTIVE: A protective association between higher vitamin D levels and the onset of multiple sclerosis (MS) has been demonstrated; however, its role in modulating MS clinical course has been little studied. We investigated whether higher levels of serum 25-hydroxyvitamin D (25-OH-D) were associated with a lower risk of relapses in people with MS.

METHODS: We conducted a prospective cohort study of 145 participants with relapsing-remitting MS from 2002 to 2005. Serum 25-OH-D levels were measured biannually, and the hazard of relapse was assessed using survival analysis.

RESULTS: There was an inverse linear relationship between 25-OH-D levels and the hazard of relapse over the subsequent 6 months, with hazard ratio (HR) 0.91 (95% confidence interval [CI]: 0.85-0.97) per 10nmol/l increase in 25-OH-D level (p = 0.006). When variation due to timing of blood collection was removed by estimating 25-OH-D at the start of each season, this association persisted, with HR 0.90 (95% CI, 0.83-0.98) per 10nmol/l increase (p = 0.016). Taking into account the biological half-life of 25-OH-D, we estimated 25-OH-D at monthly intervals, resulting in a slightly enhanced association, with HR 0.88 (95% CI, 0.82-0.95) per 10nmol/l increase (p = 0.001). Adjusting for potential confounders did not alter these findings.

INTERPRETATION: In this prospective population-based cohort study, in a cohort largely on immunomodulatory therapy, higher 25-OH-D levels were associated with a reduced hazard of relapse. This occurred in a dose-dependent linear fashion, with each 10nmol/l increase in 25-OH-D resulting in up to a 12% reduction in risk of relapse. Clinically, raising 25-OH-D levels by 50nmol/l could halve the hazard of a relapse. ANN NEUROL 2010;68:193-203.

Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I.

Menzies Research Institute

Sources: Ann Neurol. 2010 Aug;68(2):193-203. & Pubmed PMID: 20695012 (11/08/10)

msrc.co.uk

Orange juice same as supplements for vitamin D: Coca-Cola study

Thursday, June 3rd, 2010 | Tags: , , , ,
Posted in Uncategorized

 

Fortification of orange juice with either vitamin D2 or D3 produces the same increases in blood levels as consuming either vitamin via capsules, says a new study.

Vitamin D in the D2 or D3 form is “equally bioavailable in orange juice and capsules”, according to a study led by Michael Holick from Boston University and funded by the US National Institutes of Health (NIH) and the Beverage Institute for Health & Wellness, a division of Coca-Cola North America.

Several studies have reported that vitamin D2 is between 30 and 50 per cent less effective as the D3 form in maintaining blood levels in humans.

The new study, published in the American Journal of Clinical Nutrition, could challenge this view however. Holick and his co-workers arrived at their conclusion after performing a randomized, placebo-controlled, double-blind study with over 100 health adults.

Vitamin D refers to two biologically inactive precursors – D3, also known as cholecalciferol, and D2, also known as ergocalciferol. The former is produced in the skin on exposure to UVB radiation (290 to 320 nm). The latter is derived from plants and only enters the body via the diet.

Both D3 and D2 precursors are hydroxylated in the liver and kidneys to form 25- hydroxyvitamin D (25(OH)D), the non-active ’storage’ form, and 1,25-dihydroxyvitamin D (1,25(OH)2D), the biologically active form that is tightly controlled by the body.

While our bodies do manufacture vitamin D on exposure to sunshine, the levels in some northern countries are so weak during the winter months that our body makes no vitamin D at all, meaning that dietary supplements and fortified foods are seen by many as the best way to boost intakes of vitamin D.

According to Holick and his colleagues, vitamin D is already used to fortify orange juice, and is often added in combination with calcium. “[However,] it is unknown whether vitamin D is as bioavailable from orange juice as it is from supplements,” they said.

Study details

In order to answer this question, the researchers randomly divided the participants into six groups, each with between 15 and 20 people per group. The adults, aged between 18 and 84, received 1,000 international units (IU) of vitamin D2 or D3 in orange juice or capsule form, or placebo in juice or capsule form, for 11 weeks. The study occurred at the end of winter.

Results showed that 64 per cent of the participants were vitamin D deficient at the start of the study, with 25(OH)D blood levels lower than 20 nanograms per millilitre (ng/ml). At the end of the study period, the data showed no difference between 25(OH)D levels in any of the groups receiving the vitamin.

The results appear to support earlier findings by Holick’s team. In 2008, the Boston-based researchers reported finding from a three-month study with 68 subjects found that supplementation with both forms of the vitamin produced similar results. The findings were published in the Journal of Clinical Endocrinology & Metabolism (Vol. 93, pp. 677-681).

However, researchers from Creighton University in Omaha reported in 2004 that while both forms of the vitamin do produce similar rises in serum concentration of the native vitamin, indicating equivalent absorption, only vitamin D3 sustained 25(OH)D levels over a 14 day period. However, serum 25OHD fell rapidly in the D2-supplemented subjects and was not different from baseline at 14 days.

Source: American Journal of Clinical Nutrition
Published online ahead of print, doi: 10.3945/ajcn.2009.27972
“Fortification of orange juice with vitamin D2 or vitamin D3 is as effective as an oral supplement in maintaining vitamin D status in adults”
Authors: R.M. Biancuzzo, A. Young, D. Bibuld, M.H. Cai, M.R. Winter, E.K. Klein, A. Ameri, R. Reitz, W. Salameh, T.C. Chen, M.F. Holick

Study explores link between sunlight, multiple sclerosis

Monday, March 22nd, 2010 | Tags: ,
Posted in Uncategorized

For more than 30 years, scientists have known that multiple sclerosis (MS) is much more common in higher latitudes than in the tropics. Because sunlight is more abundant near the equator, many researchers have wondered if the high levels of vitamin D engendered by sunlight could explain this unusual pattern of prevalence.

Vitamin D may reduce the symptoms of MS, says Hector DeLuca, Steenbock Research Professor of Biochemistry at University of Wisconsin-Madison, but in a study published in PNAS this week, he and first author Bryan Becklund suggest that the ultraviolet portion of sunlight may play a bigger role than vitamin D in controlling MS.

is a painful neurological disease caused by a deterioration in the nerve’s electrical conduction; an estimated 400,000 people have the disabling condition in the United States. In recent years, it’s become clear the patients’ immune systems are destroying the electrical insulation on the .

The ultraviolet (UV) portion of sunlight stimulates the body to produce vitamin D, and both vitamin D and UV can regulate the immune system and perhaps slow MS. But does the immune regulation result directly from the UV, indirectly from the creation of vitamin D, or both?

The study was designed to distinguish the role of vitamin D and UV light in explaining the high rate of MS away from the equator, says DeLuca, a world authority on vitamin D.

“Since the 1970s, a lot of people have believed that sunlight worked through vitamin D to reduce MS,” says DeLuca. “It’s true that large doses of the active form of vitamin D can block the disease in the . That causes an unacceptably high level of calcium in the blood, but we know that people at the equator don’t have this high blood calcium, even though they have a low incidence of MS. So it seems that something other than vitamin D could explain this geographic relationship.”

Using mice that are genetically susceptible to MS-like disease, the researchers triggered the disease by injecting a protein from nerve fibers. The researchers then exposed the mice to moderate levels of UV radiation for a week. After they initiated disease by injecting the protein, they irradiated the mice every second or third day.

The UV exposure (equivalent to two hours of direct summer sun) did not change how many mice got the MS-like disease, but it did reduce the symptoms of MS, especially in the animals that were treated with UV every other day, DeLuca says.

The research group also found that although the UV exposure did increase the level of , that effect, by itself, could not explain the reduced MS symptoms.

In some situations, radiation does reduce immune reactions, but it’s not clear what role that might play in the current study. “We are looking to identify what compounds are produced in the skin that might play a role, but we honestly don’t know what is going on,” DeLuca says. “Somehow it makes the animal either tolerate what’s going on, or have some reactive mechanism that blocks the autoimmune damage.”

MS is a progressive neurological disease with few effective treatments, but DeLuca stresses that the study, however hopeful, may or may not lead to a new mode of treatment. “There are several ways this could go. If we can find out what the UV is producing, maybe we could give that as a medicine. In the short term, if we can define a specific wavelength of light that is active, and it does not overlap with the wavelengths that cause cancer, we could expose patients who have been diagnosed with MS to that wavelength.”

Does this information change the common prescription to avoid excessive sun exposure? “If you have an early bout with MS, then you have to think about your options,” says DeLuca. “Remember, this is just experimental work at this stage. Whether it can be translated into practical applications on MS remains to be seen.”

The study results are published this week in the Proceedings of the National Academy of Sciences.

Two studies hope to test the benefits of vitamin D once and for all

Thursday, March 11th, 2010 | Tags: , , , , , ,
Posted in Uncategorized

Two major clinical trials are just beginning in the United States that will likely settle, once and for all, whether everyone living at northern latitudes should pop a vitamin D pill every day to help ward off cancer, heart disease, and a host of other serious ailments.

The trials will also test the benefits of calcium supplements and omega-3 fatty acids, two other nutrients that also have gained a widespread following over their purported health benefits.

Hopes are high that the research studies will end the debate over the sunshine vitamin because they will be using relatively high doses – 2,000 International Units – a day, and involve more than 22,000 people, a large enough group to uncover any benefits or risks.

Both trials have been designed specifically to test the nutrient’s possible role in preventing cancer, perhaps the most dramatic medical claim that has been made about the vitamin.

“We’re not going to change formal public policy [about taking vitamin D] until we have at least one randomized trial with a primary outcome being cancer,” says Joan Lappe, a professor at Creighton University in Nebraska, and the lead researcher on one of the trials.

Dr. Lappe’s review will involve 2,300 postmenopausal women, who will be tracked for four years to check whether the vitamin reduces cancer rates, along with the incidence of cardiovascular disease and diabetes. Some of the women will also be given calcium.

The other trial, which will involve 20,000 people, is being run jointly by Harvard Medical School and the Brigham and Women’s Hospital in Boston. It will also test the theory that fish oils are good for heart health and stroke prevention, and will run for about seven years.

Both studies are receiving funds from the U.S. National Institutes of Health.

Vitamin D has acquired its health-cult status because many studies have found that people with more of the nutrient circulating in their blood have lower rates of some cancers. As well, other research – based on epidemiology or the study of disease distribution in large populations – has found that there is more cancer, diabetes, and other chronic ailments among those living at northern latitudes than among people living further south.

This peculiar south-to-north pattern of increasing incidence of many diseases suggests a possible role for vitamin D because most of this nutrient is made in the skin when cholesterol in it is exposed to strong, ultraviolet light – hence the sunshine vitamin moniker.

Light isn’t intense enough to make the vitamin the natural way in northern countries like Canada for nearly six months every fall and winter, causing many people who aren’t supplementing to have seasonal deficiencies and possibly putting them at risk of illness.

While epidemiology has been suggestive of benefits from vitamin D – it was the research technique used to finger cigarettes as a cancer risk – it has the drawback of not constituting proof in the same way as a drug-style clinical trial involving some people taking medication and others a dummy pill, the gold standard for proving the efficacy of any treatment.

The idea that a vitamin deficiency may cause cancer and many other illnesses is also such an unconventional one that it has prompted disputes within the medical research community, with doctors who are skeptical arguing that before people start taking large amounts, physicians should be certain both of its efficacy and potential side effects.

The researchers involved in the trials are also urging caution.

“We have to be careful before jumping on the bandwagon to take megadoses of supplements before we have conclusive answers from randomized trials,” says JoAnn Manson, co-leader of the Harvard/Brigham study and a professor of medicine at Harvard Medical School.

Another factor suggesting a careful approach is that many nutrients, such as vitamin C and beta-carotene, once as hyped as vitamin D, failed to live up to initial, hopeful research after drug-style trials didn’t find the value in taking them, according to Dr. Manson.

But those who have been urging wider usage of vitamin D say the evidence is already compelling and that people shouldn’t wait for the trial results to start supplementing.

“People should not remain vitamin D deficient,” says John Cannell, head of the Vitamin D Council, a California-based non-profit group that has been advocating widespread use of the nutrient as a public health measure.

Dr. Cannell says that when it comes to vitamin D, physicians have an obligation to “act based upon what is currently known, not waiting for what is going to be known in the future.”

But Dr. Manson says that there may be early indications of the results from her research. For ethical reasons, those participating in the study will be monitored for both harmful effects and benefits, which if found, may cause the trial to be altered.

How much vitamin D should you take?

The doses used in the clinical trials checking vitamin D’s anti-cancer properties will be 2,000 International Units a day, Health Canada’s maximum safe level. This is the equivalent of two typical over-the-counter pills and is designed to raise blood levels of the nutrient to concentrations associated with lower cancer risk in previous epidemiological research.

The Canadian Cancer Society has been recommending 1,000 International Units a day, with whites taking that amount in fall and winter and those with dark skin year-round because non-whites don’t make the vitamin as quickly in Canada’s relatively feeble sunlight.

The cancer society made the recommendation following the publication of study in 2007, the first of its kind, finding that about 1,100 International Units taken daily had anti-cancer properties.

Health Canada says people need take only 200 International Units to 600 International Units a day, depending on age, a recommendation based on vitamin D’s well recognized role in promoting bone health.

There are very few dietary sources of the nutrient, making it hard to get large amounts from food. Fortified milk has 100 International Units per cup. Wild salmon is one of the best natural sources, at about 800 International Units per serving. Eggs contains about 25 International Units per yoke.

Previous research has found that a vitamin D intake of around 400 International Units per day doesn’t have anti-cancer properties.